FDA Approved: VIIBRYD — Supplemental Application (Allergan, Inc.)

View source ↗

Summary

The FDA approved Allergan's supplemental application for Viibryd (vilazodone hydrochloride). The action pertains to a supplemental submission to the NDA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Viibryd (vilazodone)

Snippet

SUPPL AP for VIIBRYD (VILAZODONE HYDROCHLORIDE)